Results 181 to 190 of about 87,437 (368)

No impact of high‐dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission [PDF]

, 2000
Jean‐Yves Cahn, Myriam Labopin, Jorge Sierra, Didier Blaise, Josy Reiffers, A Ferrant, Lothar Bergmann, Giuseppe Visani, J.J. Cornelissen, Theo De Witte, Alberto Bosi, Francesco Frassoni, Norbert Claude Gorin   +12 more
openalex   +1 more source

Acute lymphoblastic B‐cell leukemia or CAR‐T cell related skin changes – a relevant diagnostic challenge

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Farzan Solimani, Amrei Dilling, Konrad Heisterkamp, Frederik Damm, Olaf Penack, Christian Oberender, Philipp Le‐Coutre, Martina Rudelius, Kamran Ghoreschi, Alexander Nast   +9 more
wiley   +1 more source

Prognostic Value of Molecular Genetic Measurable Residual Disease (MRD) Monitoring in Pediatric Acute Myeloid Leukemia Expressing KMT2A::MLLT10

European Journal of Haematology, Volume 115, Issue 5, Page 493-504, November 2025.
ABSTRACT Objectives Pediatric AML with KMT2A::MLLT10 accounts for 10%–15% of KMT2A‐rearranged AML and is associated with poor prognosis. Lately, the assessment of measurable residual disease (MRD) by reverse transcription quantitative polymerase chain reaction (RT‐qPCR) has become an important tool for disease management; however, in the pediatric ...
Emma Steidel, Eser Orhan, Mareike Rasche, Martina Pigazzi, Claudia Tregnago, Lina Marie Hoffmeister, Christiane Walter, Michael Dworzak, Nora Mühlegger, Nils von Neuhoff, Franco Locatelli, Dirk Reinhardt, Markus Schneider   +12 more
wiley   +1 more source

Apoptosis regulators of the Bcl‐2 family play a key role in chemoresistance of cholangiocarcinoma organoids

International Journal of Cancer, Volume 157, Issue 8, Page 1694-1708, 15 October 2025.
What's New? Poor prognosis in cholangiocarcinoma (CCA) is attributed to late diagnosis and intrinsic chemoresistance. In particular, resistance mechanisms that suppress apoptosis limit the effectiveness of gemcitabine‐based regimens, which remain the standard treatment.
Wunan Mi, Gilles S. van Tienderen, Shaojun Shi, Amy Broeders, Kathryn Monfils, Henk P. Roest, Luc J. W. van der Laan, Monique M. A. Verstegen   +7 more
wiley   +1 more source

Acute cerebellar syndrome following intermediate‐dose cytarabine [PDF]

, 2001
Moshe Yeshurun, K Dupuch
openalex   +1 more source

Strategies to Design and Optimize Artificial Antigen‐Presenting Cells for T Cell Expansion in Cancer Immunotherapy

Advanced Functional Materials, Volume 35, Issue 41, October 8, 2025.
This review highlights recent advances in engineering artificial antigen‐presenting cells (aAPCs) as alternatives to dendritic cells for T cell expansion. Key design principles inspired by the immunological synapse are discussed, with emphasis on strategies for polyclonal and antigen‐specific T cell expansion.
Nguyen Thi Nguyen, Yu Seok Youn
wiley   +1 more source

Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma [PDF]

, 2020
al., et, Bartlett, Nancy L., Cashen, Amanda, Edwin, Natasha, Ghobadi, Armin, Kahl, Brad, Mehta-Shah, Neha, Merryman, Reid W.   +7 more
core   +1 more source

Amsacrine with high-dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adults

, 1988
Arlin Za, Eric J. Feldman, Sanford Kempin, Tauseef Ahmed, Abraham Mittelman, S. Savona, Joad L. Ascensao, Paul Baskind, Phyllis Sullivan, HG Fuhr   +9 more
openalex   +1 more source

Epigenetic Regulation of DAPK1 and Netrin‐1 Drives Diabetic Encephalopathy

Advanced Science, Volume 12, Issue 37, October 6, 2025.
This study identifies a microRNA (miR)‐216a‐5p/death‐associated protein kinase 1 (DAPK1)/hepatocyte nuclear factor 1 homeobox A (HNF1A)/Netrin‐1 signaling axis in diabetic encephalopathy (DE). In leptin receptor‐deficient (db/db) and streptozotocin (STZ)‐induced diabetic mice, reduced miR‐216a‐5p increases DAPK1 expression, disrupting HNF1A binding to ...
Yang Zhou, Jia‐Xin Kou, Kai Zheng, Zi‐Xuan Guo, Hong‐Wei Fan, Wen‐Lian Li, Lu‐Lu Chu, Jing‐Wen Yin, Li‐Jie Liu, Nadezhda Brazhe, Zhi‐Gao Xiang, Feng Hu, Kai Shu, Ling‐Qiang Zhu, Dan Liu   +14 more
wiley   +1 more source

Comparison of cyclophosphamide, cytarabine, and etoposide as immunosuppressive agents before allogeneic bone marrow transplantation

, 1988
Walter Gassmann, L. Uharek, H-U. Wottge, Norbert Schmitz, H. Löffler, W Mueller-Ruchholtz   +5 more
openalex   +1 more source